Overview
Carrie Van Der Weyden practices practicing medicine in Melbourne, Australia.
Ms. Van Der Weyden is highly rated in 6 conditions, according to our data. Her clinical expertise encompasses T-Cell Lymphoma, Cutaneous T-Cell Lymphoma (CTCL), Sezary Syndrome, and Mycosis Fungoides.
She is actively involved in clinical research, co-authoring 42 peer reviewed articles.
Gender
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Carrie A. Van Der Weyden
Is Carrie A. Van Der Weyden a top-rated expert for T-Cell Lymphoma?
MediFind is an objective health platform that identifies experts based on real-world data. Carrie A. Van Der Weyden is classified as an Distinguished expert for T-Cell Lymphoma, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Carrie A. Van Der Weyden participate in research or clinical trials?
Yes. Carrie A. Van Der Weyden has published 42 articles and abstracts on conditions like T-Cell Lymphoma. You can view a list of Carrie A. Van Der Weyden's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- Cutaneous T-Cell Lymphoma (CTCL)Ms. Van Der Weyden isDistinguished. Learn about Cutaneous T-Cell Lymphoma (CTCL).
- Mycosis FungoidesMs. Van Der Weyden isDistinguished. Learn about Mycosis Fungoides.
- Sezary SyndromeMs. Van Der Weyden isDistinguished. Learn about Sezary Syndrome.
- T-Cell LymphomaMs. Van Der Weyden isDistinguished. Learn about T-Cell Lymphoma.
- Advanced
- Non-Hodgkin LymphomaMs. Van Der Weyden isAdvanced. Learn about Non-Hodgkin Lymphoma.
- Peripheral T-Cell LymphomaMs. Van Der Weyden isAdvanced. Learn about Peripheral T-Cell Lymphoma.
- Experienced
- Anaplastic Large Cell LymphomaMs. Van Der Weyden isExperienced. Learn about Anaplastic Large Cell Lymphoma.
- Angioimmunoblastic T-cell LymphomaMs. Van Der Weyden isExperienced. Learn about Angioimmunoblastic T-cell Lymphoma.
- Hodgkin LymphomaMs. Van Der Weyden isExperienced. Learn about Hodgkin Lymphoma.
- Langerhans Cell HistiocytosisMs. Van Der Weyden isExperienced. Learn about Langerhans Cell Histiocytosis.
- Lymphofollicular HyperplasiaMs. Van Der Weyden isExperienced. Learn about Lymphofollicular Hyperplasia.
- Lymphomatoid PapulosisMs. Van Der Weyden isExperienced. Learn about Lymphomatoid Papulosis.